These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30395829)

  • 41. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.
    Gao Z; Li Z; Yan J; Wang P
    Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intracellularly Degradable, Self-Assembled Amphiphilic Block Copolycurcumin Nanoparticles for Efficient In Vivo Cancer Chemotherapy.
    Lv L; Guo Y; Shen Y; Liu J; Zhang W; Zhou D; Guo S
    Adv Healthc Mater; 2015 Jul; 4(10):1496-501, 1423. PubMed ID: 26033838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
    Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
    Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy.
    Yang H; Shen W; Liu W; Chen L; Zhang P; Xiao C; Chen X
    Biomacromolecules; 2018 Nov; 19(11):4492-4503. PubMed ID: 30346147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy.
    Handali S; Moghimipour E; Rezaei M; Saremy S; Dorkoosh FA
    Int J Biol Macromol; 2019 Mar; 124():1299-1311. PubMed ID: 30248424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
    Sen K; Banerjee S; Mandal M
    Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy.
    Wang T; Zhang J; Hou T; Yin X; Zhang N
    Nanoscale; 2019 Aug; 11(29):13934-13946. PubMed ID: 31305839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Redox responsive xylan-SS-curcumin prodrug nanoparticles for dual drug delivery in cancer therapy.
    Sauraj ; Vinay Kumar ; Kumar B; Priyadarshi R; Deeba F; Kulshreshtha A; Kumar A; Agrawal G; Gopinath P; Negi YS
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110356. PubMed ID: 31761247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dual-drug loaded nanoneedles with targeting property for efficient cancer therapy.
    Yang X; Wu S; Xie W; Cheng A; Yang L; Hou Z; Jin X
    J Nanobiotechnology; 2017 Dec; 15(1):91. PubMed ID: 29258613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synergistic cytotoxicity of the poly (ADP-ribose) polymerase inhibitor ABT-888 and temozolomide in dual-drug targeted magnetic nanoparticles.
    Muñoz-Gámez JA; López Viota J; Barrientos A; Carazo Á; Sanjuán-Nuñez L; Quiles-Perez R; Muñoz-de-Rueda P; Delgado Á; Ruiz-Extremera Á; Salmerón J
    Liver Int; 2015 Apr; 35(4):1430-41. PubMed ID: 24821649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone.
    Liu J; Zeng Y; Shi S; Xu L; Zhang H; Pathak JL; Pan Y
    Int J Nanomedicine; 2017; 12():3561-3575. PubMed ID: 28507436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan.
    Emami J; Maghzi P; Hasanzadeh F; Sadeghi H; Mirian M; Rostami M
    Pharm Dev Technol; 2018 Jan; 23(1):41-54. PubMed ID: 28608760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elaboration and characterization of curcumin-loaded Tri-CL-mPEG three-arm copolymeric nanoparticles by a microchannel technology.
    Wu W; Wu J; Fu Q; Jin C; Guo F; Yan Q; Yang Q; Wu D; Yang Y; Yang G
    Int J Nanomedicine; 2019; 14():4683-4695. PubMed ID: 31308653
    [No Abstract]   [Full Text] [Related]  

  • 56. Characteristics and cytotoxicity of folate-modified curcumin-loaded PLA-PEG micellar nano systems with various PLA:PEG ratios.
    Phan QT; Le MH; Le TT; Tran TH; Xuan PN; Ha PT
    Int J Pharm; 2016 Jun; 507(1-2):32-40. PubMed ID: 27150945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
    Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
    Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
    [No Abstract]   [Full Text] [Related]  

  • 58. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
    Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
    Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biodistribution and biocompatibility of glycyrrhetinic acid and galactose-modified chitosan nanoparticles as a novel targeting vehicle for hepatocellular carcinoma.
    Li M; Wang Y; Jiang S; Gao Y; Zhang W; Hu S; Cheng X; Zhang C; Sun P; Ke W; Wang G; Song Z; Zhang Y; Zheng QC
    Nanomedicine (Lond); 2020 Jan; 15(2):145-161. PubMed ID: 31782335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.